Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol:
CFI
Name:
complement factor I
Location:
04q25
Locus Group:
protein-coding gene
Gene Type:
Protein Coding
Locus Type:
gene with protein product
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all
Clinical Studies
| NCT Number | Status | Brief Title | View |
|---|---|---|---|
| NCT01625832 | Effects of Coronary Sinus Occlusion on Myocardial Ischemia Pilot Study | View | |
| NCT01440296 | Magnetic Resonance Imaging MRI Characterization of Carotid Plaque and Prediction of End-organ and Clinical Outcomes | View | |
| NCT04256811 | DCTMD Axis I for Children | View | |
| NCT03044145 | The Cultural Formulation Interview-Engagement Aid | View | |
| NCT04494555 | Do Adaptable Sockets Improve Military Performance | View | |
| NCT05072912 | Screening Study to Identify Patients With Complement Factor I Deficiencies | View | |
| NCT05788315 | The Influence of the Cultural Formulation Interview on Therapeutic Work Alliance | View | |
| NCT02332564 | Coronary Steal Via Natural Internal Mammary Artery-To-Coronary Artery Bypasses | View | |
| NCT00414297 | External Counterpulsation ECP for the Promotion of Collateral Growth in Patients With Coronary Artery Disease | View | |
| NCT00596479 | Filgrastim for the Promotion of Collateral Growth in Patients With CAD | View | |
| NCT04647318 | Physiological Response to Self-compassion Versus Relaxation | View | |
| NCT01708135 | Feasibility of Use of BariCare App in Pre-bariatric Surgery | View | |
| NCT01157299 | Hemodynamic Evaluation of Preload Responsiveness in Children by Using PiCCO | View | |
| NCT05080023 | Impact of Enhanced External Counterpulsation EECP on Cardiac Force Index | View | |
| NCT05095623 | A Natural History Study to Assess the Clinical Outcomes of Patients With Complement Factor I Deficiency-Mediated Disease | View | |
| NCT01859104 | Feasibility of Use of BariCare App in Pre-transplant Population | View | |
| NCT01954316 | A Study of CFI-400945 Fumarate in Patients With Advanced Cancer | View | |
| NCT03568422 | CFI-402257 in Combination With Paclitaxel in Patients With AdvancedMetastatic HER2-Negative Breast Cancer | View | |
| NCT02792465 | A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors | View | |
| NCT06163339 | Evaluation of the Cultural Formulation Interview CFI | View | |
| NCT03499600 | Improving Satisfaction Engagement and Outcomes Among Traditionally Underserved Children Through Cultural Formulation | View | |
| NCT03624543 | CFI-400945 in Patients With AdvancedMetastatic Breast Cancer | View | |
| NCT04730258 | A Study of CFI-400945 With or Without Azacitidine in Patients With AML MDS or CMML | View | |
| NCT04176848 | CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer | View | |
| NCT04878757 | Implementing Inclusive Fraction Intervention Classwide | View | |
| NCT05227040 | Effect of the Nintendo Ring Fit Adventure Exergame on Running Completion Time | View | |
| NCT05251714 | CFI-402257 a Potent and Selective TTK Inhibitor in Solid Tumors and With Fulvestrant in Breast Cancer | View | |
| NCT05613829 | Frailty Index and Mortality After a Burn Surgery | View | |
| NCT01090908 | Evaluation of Ciprofloxacin for Inhalation to Cystic Fibrosis Patients With P Aeruginosa | View | |
| NCT06539091 | Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer | View | |
| NCT04521413 | Safety and Efficacy Study of CFI-402411 in Subjects With Advanced Solid Malignancies | View | |
| NCT03187288 | Study of CFI-400945 Fumarate in Patients With Relapsed or Refractory AML or MDS | View |